Abstract

Background: Diagnosis of chronic hepatitis C virus (HCV) infection typically involves collection of venous blood samples prior to serological investigation of an antibody response followed by a confirmatory viral load or antigen test to verify active HCV infection. This conventional pathway poses logistical challenges for the implementation of reflex testing, whereby the confirmatory test is performed on the same sample used for serological investigation. Dried blood spot (DBS) testing, in which capillary blood is deposited on filter paper, is a less invasive alternative that can enable reflex testing without the need for venepuncture, centrifugation and freezing of samples. Methods: This systematic review aims to assess the diagnostic accuracy of DBS compared with venous blood samples for diagnosis of chronic HCV infection. Observational studies which compare diagnostic tests using DBS with those using serum, plasma or whole blood in patients with chronic or resolved HCV infection will be included. Electronic searches will be conducted in PubMed, Embase, Scopus, Web of Science, Lilacs and the Cochrane library. Citation screening, data extraction and quality appraisal of included studies will be performed in duplicate using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. A meta-analysis will be conducted to derive pooled estimates of sensitivity, specificity, positive likelihood ratios, negative likelihood ratios, and diagnostic odds ratios. Sensitivity analyses and meta-regression will also be performed. Quality of the evidence will be evaluated using the GRADE criteria. Discussion: Identifying and linking people with currently undiagnosed chronic HCV infection to care is pivotal to attaining global viral hepatitis elimination targets. The use of DBS could simplify diagnostic testing strategies by integrating reflex testing into the care pathway and reducing drop-off along the cascade of care. Registration: PROSPERO, CRD42020205204. Registered 19 th September 2020.

Highlights

  • The hepatitis C virus (HCV), first identified in 1989, is a blood borne virus which infects the liver and commonly causes progressive liver disease[1]

  • The aim of this systematic review is to assess the diagnostic accuracy of Dried blood spot (DBS) samples compared with venous blood samples for detection of HCV using laboratory-based tests

  • Recent advances in HCV therapies have led to a paradigm shift towards identifying and curing those currently living with chronic HCV infection with the aim of achieving the World Health Organization’s viral hepatitis elimination targets by 20302,9

Read more

Summary

Discussion

Recent advances in HCV therapies have led to a paradigm shift towards identifying and curing those currently living with chronic HCV infection with the aim of achieving the World Health Organization’s viral hepatitis elimination targets by 20302,9. While no DBS assays are currently commercially available for diagnosis of HCV infection[19,45], growing interest in its “off-label” use has led to the development of standardised laboratory protocols for using DBS samples in immunoassay and molecular techniques[46]. The aim of this systematic review is to assess the diagnostic accuracy of DBS samples compared with venous blood samples for detection of HCV using laboratory-based tests (that is, antiHCV, RNA and core antigen). Extended data Open Science Framework: Laboratory-based dried blood spot testing for hepatitis C: A protocol for systematic review and meta-analysis of diagnostic accuracy. Reporting guidelines PRISMA-P checklist for “Laboratory-based dried blood spot testing for hepatitis C: A protocol for systematic review and meta-analysis of diagnostic accuracy.” https://osf.io/ghx52/files/28.

Introduction
Methods
World Health Organization
14. European Centre for Disease Prevention and Control
16. Lim MD: Dried Blood Spots for Global Health Diagnostics and Surveillance
26. Health Information and Quality Authority
28. Carty P
30. Health Information and Quality Authority
33. World Health Organization
43. World Health Organization
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.